<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo> is a devastating disease and the WHO [World Health Report, World Health Organization, 2002] (World Health Organization) expects that the number of diabetic patients will increase to 300 million by the year 2025 </plain></SENT>
<SENT sid="1" pm="."><plain>Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> results from an autoimmune-mediated destruction of the insulin-secreting beta-cells in the islets of Langerhans of the pancreas, whereas Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is a disease of the older population which is due to systemic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> by the pancreatic beta-cells </plain></SENT>
<SENT sid="2" pm="."><plain>Surgical resection of the pancreas may also cause <z:mp ids='MP_0002056'>insulin-dependent diabetes</z:mp> depending on the size of the remaining pancreas </plain></SENT>
<SENT sid="3" pm="."><plain>The long-term complications of <z:mp ids='MP_0002055'>diabetes</z:mp> are a direct result of the constantly elevated levels of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> in the absence of an effective insulin treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Recent prospective studies such as the <z:mp ids='MP_0002055'>diabetes</z:mp> control and complication trial (DCCT) [N </plain></SENT>
<SENT sid="5" pm="."><plain>Engl </plain></SENT>
<SENT sid="6" pm="."><plain>J </plain></SENT>
<SENT sid="7" pm="."><plain>Med </plain></SENT>
<SENT sid="8" pm="."><plain>329 (1993) 977] and the UK prospective <z:mp ids='MP_0002055'>diabetes</z:mp> study [Lancet 352 (1998) 837] have convincingly demonstrated that improved blood <z:chebi fb="105" ids="17234">glucose</z:chebi> control in <z:hpo ids='HP_0000001'>all</z:hpo> type <z:mp ids='MP_0002055'>diabetes</z:mp> reduces the risk of the development of the secondary complications of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Despite intensive insulin therapy, most individuals with insulin deficient <z:mp ids='MP_0002055'>diabetes</z:mp> are unable to maintain a blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level in the <z:mpath ids='MPATH_458'>normal</z:mpath> range at <z:hpo ids='HP_0000001'>all</z:hpo> times </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, the only way to ensure the long-term health of patients with <z:mp ids='MP_0002055'>diabetes</z:mp> is find a way of maintaining constant normoglycemia </plain></SENT>
<SENT sid="11" pm="."><plain>It seems logical that the replacement of the islet tissue itself, either by transplanting a vascularized pancreatic allograft or by transplanting purified pancreatic islet cells, offers a better approach than simply replacing insulin that has been lost </plain></SENT>
<SENT sid="12" pm="."><plain>In this article, we outline the major achievements made recently in the development of therapeutic islet transplantation applications and offer an explanation as to why islet transplantation seems to be an ideal solution for absolute insulin deficient <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>